Researchers evaluate the risks of possible adverse events following COVID-19 mRNA vaccination in the elderly.
A novel approach to IV access
Editor’s note: Joseph Smith is chief scientific officer of BD, which makes instrument systems and medical devices, including equipment for vascular access management. Views are